Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease

Thorax

Volumn 62, Issue 2, 2007, Pages 115-120

  Swallow, Elisabeth B ^a   Reyes, Diana ^a   Hopkinson, Nicholas S ^a   Man, William D C ^b   Porcher, Raphaël ^c   Cetti, Edward J ^a   Moore, Alastair J ^a   Moxham, John ^b   Polkey, Michael I ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE STRENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUESTIONNAIRE;

DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE;

EID: 33847036326     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.062026     Document Type: Article

References (33)

1. World Health Organization. World Health Report. Geneva: WHO, 2000.
2. Celli BR, Cote CG, Marin JM, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
3. Schols AMWJ, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998;157:1791-7.
4. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
5. Prescott E, Almdal T, Mikkelsen KL, et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002;20:539-44.
6. Chailleux E, Laaban J-P, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003;123:1460-6.
7. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-13.
8. Slinde F, Gronberg A, Engstrom C-P, et al. Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients. Respir Med 2005;99:1004-9.
9. Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MA, et al. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 2005;128:2108-15.
10. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
11. Baarends E, Schols A, Mostert R, et al. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2807-13.
12. Schols AM, Mostert R, Soeters PB, et al. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991;46:695-9.
13. Sahebjami H, Sathianpitayakul E. Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:886-90.
14. Mostert R, Goris A, Weling-Scheepers C, et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-67.
15. Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152(Pt 1):2021-31.
16. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
17. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
18. Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544-9.
19. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention or chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
20. Steiner MC, Barton RL, Singh SJ, et al. Bedside methods versus dual energy x rayabsorptiometry for body composition measurement in COPD. Eur Respir J 2002;19:626-31.
21. Edwards RH, Young A, Hosking GP, et al. Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 1977;52:283-90.
22. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515- 26.
23. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med 2004;23:723-48.
24. Kent JT, O'Quigley J. Measures of dependence for censored survival data. Biometrika 1988;75:525-34.
25. Man WD, Moxham J, Polkey MI. Magnetic stimulation for the measurement of respiratory and skeletal muscle function. Eur Respir J 2004;24:846-60.
26. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol 2006;61:72-7.
27. Hopkinson NS, Nickol AH, Poyne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:395-9.
28. Gea JG, Pasto M, Carmona MA, et al. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 2001;17:939-45.
29. Man WD, Soliman MG, Nikoletou D, et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 2003;58:665-9.
30. Man WD-C, Hopkinson NS, Harraf F, et al. Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease. Thorax 2005;60:718-22.
31. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003;58:752-6.
32. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58:100-5.
33. Man WD-C, Polkey MI, Donaldson N, et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004;329:1209.